Compare HRZN & NHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | HRZN | NHS |
|---|---|---|
| Founded | 2008 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Trusts Except Educational Religious and Charitable |
| Sector | Finance | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 322.2M | 259.9M |
| IPO Year | N/A | N/A |
| Metric | HRZN | NHS |
|---|---|---|
| Price | $4.67 | $6.16 |
| Analyst Decision | Hold | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $6.50 | N/A |
| AVG Volume (30 Days) | ★ 636.6K | 237.0K |
| Earning Date | 05-05-2026 | 01-01-0001 |
| Dividend Yield | ★ 33.85% | 13.44% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $12.25 | N/A |
| Revenue Next Year | $22.53 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.80 | $6.06 |
| 52 Week High | $8.46 | $7.75 |
| Indicator | HRZN | NHS |
|---|---|---|
| Relative Strength Index (RSI) | 57.03 | 39.35 |
| Support Level | $4.56 | $6.06 |
| Resistance Level | $4.74 | $6.30 |
| Average True Range (ATR) | 0.11 | 0.06 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 48.44 | 7.83 |
Horizon Technology Finance Corp is a specialty finance company. Its investment objective is to maximize its investment portfolio's total return by generating current income from the debt investments it makes and capital appreciation from the warrants it receives when making such debt investments. It lends to and invests in development-stage companies in the technology, life science, healthcare information and services, and sustainability industries.
Neuberger Berman High Yield Strategies Fund Inc is a diversified, closed-end management investment company. The company invests in high yield debt securities market. The Fund uses leverage to pursue its investment objective. The Fund may invest in a variety of direct debt instruments, including bank loans, notes and other interests in amounts owed to financial institutions by borrowers, such as companies and governments. Corporate loans in which the Fund may invest will consist of direct obligations of borrowers. The Fund may invest in corporate loans at origination as a co-lender or may acquire loans in the secondary market by purchasing participations in, assignments of or novations of corporate loans.